A new study paper on Cornavirus (COVID-19) has been published on the medrXiv preprint journal, titled: “Patient-derived mutations impact pathogenicity of SARS-CoV-2”. The research was done at the Zhejiang University in Hangzhou, China. The researchers involved in the study were: Hangping Yao, Xiangyun Lu, Qiong Chen, Kaijin Xu, Yu Chen, Linfang Cheng, Fumin Liu, Zhigang Wu, Haibo Wu, Changzhong Jin, Min Zheng, Nanping Wu, Chao Jiang, Lanjuan Li
From the study: “In total, 33 mutations were identified (including 10 mutations observed in
120 mixed-populations), and 19 of these mutations were novel, according to the comparison
121 with 1111 genomic sequences available at GISAID on 3/24/2020.”
Since there are many mutations, creating a COVID-19 Vaccine will be that much more difficult. I suspect that there are many more mutations, say in Europe. As such, I am of the opinion that a viable Vaccine will not be developed.
One can Download a PDF of the research study paper on the website via the above mentioned link to the medrXiv website.
Posted by Vincent Banial